<SEC-DOCUMENT>0000899243-21-013928-index.html : 20210330
<SEC-HEADER>0000899243-21-013928.hdr.sgml : 20210330
<ACCEPTANCE-DATETIME>20210330171214
ACCESSION NUMBER:		0000899243-21-013928
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210330
FILED AS OF DATE:		20210330
DATE AS OF CHANGE:		20210330

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
		CENTRAL INDEX KEY:			0001787092
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40236
		FILM NUMBER:		21787744

	BUSINESS ADDRESS:	
		STREET 1:		WELLINGTON ALTERNATIVE INVESTMENTS LLC
		STREET 2:		280 CONGRESS STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(617) 951-5372

	MAIL ADDRESS:	
		STREET 1:		WELLINGTON ALTERNATIVE INVESTMENTS LLC
		STREET 2:		280 CONGRESS STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edgewise Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001710072
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				821725586
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		C/O ORBIMED ADVISORS LLC
		STREET 2:		601 LEXINGTON AVE, 54TH FLR.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-739-6451

	MAIL ADDRESS:	
		STREET 1:		C/O ORBIMED ADVISORS LLC
		STREET 2:		601 LEXINGTON AVE, 54TH FLR.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>